Neurology News and Research

Latest Neurology News and Research

Neural mapping approach to re-examine previous Alzheimer's studies finds improved reproducibility

A neural mapping approach that pegs results from more than two dozen previous Alzheimer's studies found that reproducibility improves when trying to isolate symptoms to a brain network rather than a single area of the brain.

17 Dec 2018

Study finds epigenetic differences in the brains of individuals with schizophrenia

A study using a PET scan tracer developed at the Martinos Center for Biomedical Imaging at Massachusetts General Hospital has identified, for the first time, epigenetic differences between the brains of individuals with schizophrenia and those of unaffected study participants.

17 Dec 2018

Eisai enters into agreement with Eurofarma for its anti-obesity agent lorcaserin

Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride in Brazil to Eurofarma Laboratorios S.A. Under this agreement, Eisai will supply Eurofarma with lorcaserin. Eisai will receive a one-time contractual payment and is eligible for milestone payments for sales in Brazil.

17 Dec 2018

Researchers use brain connectome to reassess neuroimaging findings of Alzheimer's disease

Already affecting more than five million Americans older than 65, Alzheimer's disease is on the rise and expected to impact more than 13 million people by 2050.

17 Dec 2018

New mouse model shows potential for rapid identification of promising muscular dystrophy therapies

A Massachusetts General Hospital research team has created a new mouse model of a common form of muscular dystrophy with the potential of rapidly distinguishing promising therapeutic drugs from those unlikely to be successful.

13 Dec 2018

Scientists investigate how a painful event is processed in the brain

Pain is a negative feeling that we want to get rid of as soon as possible. In order to protect our bodies, we react for example by withdrawing the hand. This action is usually understood as the consequence of the perception of pain.

13 Dec 2018

New collaborative partnership in quest of novel antibiotics

The Global Antibiotic Research and Development Partnership, Eisai Co., Ltd. and Takeda Pharmaceutical Company Limited have signed an agreement for GARDP to access and screen components of Eisai and Takeda's chemical libraries.

12 Dec 2018

Disrupted biological clock can contribute to onset of diseases, USC study shows

USC scientists report that a novel time-keeping mechanism within liver cells that helps sustain key organ tasks can contribute to diseases when its natural rhythm is disrupted.

11 Dec 2018

Single tau molecule holds clues to help diagnose neurodegeneration in its earliest stages

Scientists who recently identified the molecular start of Alzheimer's disease have used that finding to determine that it should be possible to forecast which type of dementia will develop over time - a form of personalized medicine for neurodegenerative diseases.

11 Dec 2018

Drug repositioning strategy identifies potential new treatments for epilepsy

Drug repositioning-- taking known drugs and identifying new applications for them--is an attractive concept for speeding up the process of bringing drugs to human testing for unmet medical needs.

11 Dec 2018

Study finds 117% increase in number of dementia sufferers in 26 years

An international group of collaborating scientists that includes HSE Professor Vasily Vlasov has analyzed data from 195 countries on the spread of Alzheimer's disease and other dementia between 1990 and 2016.

11 Dec 2018

Researchers identify potential diagnostic tool for Alzheimer’s disease

Researchers at Johns Hopkins Medicine have identified in live human brains new radioactive “tracer” molecules that bind to and “light up” tau tangles, a protein associated with a number of neurodegenerative diseases including Alzheimer’s disease and other related dementias.

11 Dec 2018

Ezogabine treatment reduces motor neuron excitability in ALS patients, study shows

Brian Wainger, MD, PhD, of the Healey Center for ALS at Massachusetts General Hospital presented initial, top-level results of a recently completed phase 2 clinical trial of ezogabine (also called retigabine) on December 9 at the Motor Neurone Disease Association annual meeting in Glasgow, Scotland.

11 Dec 2018

Caffeine plus another compound in coffee may fight Parkinson’s disease

Rutgers scientists have found a compound in coffee that may team up with caffeine to fight Parkinson's disease and Lewy body dementia - two progressive and currently incurable diseases associated with brain degeneration.

10 Dec 2018

Novel therapeutic targets based on biology of aging show promise for Alzheimer's disease

A scientific strategy that explores therapeutic targets based on the biology of aging is gaining ground as an effective approach to prevent and treat Alzheimer's disease, according to research published in the December 7, 2018 online issue of Neurology.

10 Dec 2018

Mount Sinai researcher awarded $2.5 million to advance understanding of neurodegenerative diseases

Ivan Marazzi, PhD, Assistant Professor of Microbiology at the Icahn School of Medicine at Mount Sinai, was awarded $2.5 million in funding by the Chan Zuckerberg Initiative to further the understanding of the underlying causes of neurodegenerative disorders such as Lou Gehrig's, Alzheimer's, and Parkinson's diseases. The

7 Dec 2018

Researchers are developing blood test to diagnose or predict Alzheimer's disease

Today, the only way to definitively diagnose Alzheimer's disease in life is through brain scans and tests of cerebrospinal fluid that must be collected via lumbar puncture. Though cumbersome and expensive, such tests provide the most accurate diagnoses for patients.

6 Dec 2018

Individual neurons located within the brain have implications for psychiatric diseases

Everyone makes little everyday mistakes out of habit--a waiter says, "Enjoy your meal," and you respond with, "You, too!" before realizing that the person is not, in fact, going to be enjoying your meal.

6 Dec 2018

New CU Boulder study shows how spinal injury impacts circadian rhythms

In the hours and days following a spinal cord injury, the gears that control the body's internal clocks fall profoundly out of sync, impacting body temperature, hormone fluctuation, immunity and the timing of a host of other bodily processes, according to new University of Colorado Boulder research.

5 Dec 2018

Researchers create new approach to classify patients with Alzheimer's disease

Researchers studying Alzheimer's disease have created an approach to classify patients with Alzheimer's disease, a finding that may open the door for personalized treatments.

5 Dec 2018

Neurology News and Research

Latest Neurology News and Research

Neural mapping approach to re-examine previous Alzheimer's studies finds improved reproducibility

Study finds epigenetic differences in the brains of individuals with schizophrenia

Eisai enters into agreement with Eurofarma for its anti-obesity agent lorcaserin

Researchers use brain connectome to reassess neuroimaging findings of Alzheimer's disease

New mouse model shows potential for rapid identification of promising muscular dystrophy therapies

Scientists investigate how a painful event is processed in the brain

New collaborative partnership in quest of novel antibiotics

Disrupted biological clock can contribute to onset of diseases, USC study shows

Single tau molecule holds clues to help diagnose neurodegeneration in its earliest stages

Drug repositioning strategy identifies potential new treatments for epilepsy

Study finds 117% increase in number of dementia sufferers in 26 years

Researchers identify potential diagnostic tool for Alzheimer’s disease

Ezogabine treatment reduces motor neuron excitability in ALS patients, study shows

Caffeine plus another compound in coffee may fight Parkinson’s disease

Novel therapeutic targets based on biology of aging show promise for Alzheimer's disease

Mount Sinai researcher awarded $2.5 million to advance understanding of neurodegenerative diseases

Researchers are developing blood test to diagnose or predict Alzheimer's disease

Individual neurons located within the brain have implications for psychiatric diseases

New CU Boulder study shows how spinal injury impacts circadian rhythms

Researchers create new approach to classify patients with Alzheimer's disease

Aneuro: Advancing Neuroscience Research eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Neurology News and Research

Latest Neurology News and Research

Aneuro: Advancing Neuroscience Research eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in